Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2026 Earnings Call Transcript May 14, 2026
Fennec Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.02.
Operator: Good morning, ladies and gentlemen, and welcome to the Fennec Pharmaceuticals First Quarter 2026 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. I would now like to turn the conference over to Fennec’s Chief...
